Prospective Phase I/II Study of Adjuvant Radiochemotherapy for Gastric Cancer
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Phase I and II: Acute toxicity: assessed according to National Cancer Institute of Canada (NCIC) and Radiation Therapy Oncology Group (RTOG) toxicity assessment criteria.
Jolie Ringash, MD
Princess Margaret Hospital, Canada
Canada: Review Ethics Committee
UHN REB 02-0134-C